Loading...
Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention
Abciximab is a widely studied glycoprotein IIb/IIIa inhibitor, specifically in the setting of patients undergoing percutaneous coronary intervention (PCI). The populations studied have included patients with non-ST-segment acute coronary syndromes, ST-segment elevation myocardial infarction, and ele...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2835553/ https://ncbi.nlm.nih.gov/pubmed/20234778 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|